Abstract:OBJECTIVE:To investigate nerve fibers distribution in endometrium of adenomyosis and their relationship with dysmenorrhea.METHODS:Endometrial tissue was sampled from 74 hysterectomy specimens including 32 cases with adenomyosis and 42 cases with uterine fibroids. Two-step Envision immunohistochemical staining was used to detect distribution of nerve fibers in endometrium. Highly specific polyclonal rabbit anti-protein gene product 9.5 (PGP9.5) and monoclonal mouse anti-neurofilament protein (NF) were used to demonstrate both myelinated and unmyelinated nerve fibers in endometrium in women with adenomyosis and uterine fibroids.RESULTS:The positive rate of PGP9.5 immunoreactive nerve fibers in the functional layer of endometrium of pain patients were with 64% (14/22) in adenomyosis and 67% (10/15) in uterine fibroids. And their density were 0.6 (0 - 9.4)/mm(2) and 0.6 (0 - 6.0)/mm(2) without reaching statistical difference (P > 0.05). No expression of NF could be detected in the functional layer of endometrium of adenomyosis and uterine fibroids. There were no PGP9.5 immunoreactive nerve fibers in the functional layer of endometrium in non-pain women with adenomyosis and uterine fibroids. Moreover, No NF immunoreactive nerve fibers in the functional layer of endometrium were shown in non-pain patients with adenomyosis and uterine fibroids. PGP9.5 immunoreactive nerve fibers and the nerve density in the basal layer of endometrium were 64% (14/22), 1.1 (0 - 12.0)/mm(2) in pain adenomyosis and 50% (5/10), 0.6 (0 - 3.0)/mm(2) in non-pain adenomyosis. NF immunoreactive nerve fibers and the density in the basal layer of endometrium were 23% (5/22), (0 - 0.6)/mm(2) in pain adenomyosis and 20% (2/10), (0 - 1.0)/mm(2) in non-pain adenomyosis. PGP9.5 immunoreactive nerve fibers and the nerve density in the basal layer of endometrium were 80% (12/15) and 1.6 (0 - 10.0)/mm(2) in pain fibroids and 44% (12/27), 0 (0 - 5.0)/mm(2) in non-pain fibroids. NF immunoreactive nerve fibers and the nerve density in the basal layer of endometrium were 40% (6/15), 0 (0 - 0.4)/mm(2) in pain fibroids and 15% (4/27), 0 (0 - 1.0)/mm(2) in non-pain fibroids. There was no statistical different PGP9.5 and NF immunoreactive nerve fibers distribution in basal layer of endometrium between pain adenomyosis and pain fibroids or between non-pain adenomyosis and non-pain fibroids (all P > 0.05). However, PGP9.5 immunoreactive nerve fibers density in basal layer of endometrium was higher in pain adenomyosis and fibroids when compared with non-pain adenomyosis and fibroids (P < 0.05).CONCLUSIONS:PGP9.5 immunoreactive nerve fibers might confer the occurrence of pelvic pain, however, NF immunoreactive nerve fibers may not involved in the pathogenesis of pain.

Immunoreactivity of Progesterone Receptor Isoform B, Nuclear Factor Κb, and IκBα in Adenomyosis

Immunoreactivity of Progesterone Receptor Isoform B, Nuclear Factor Kappab, and IkappaBalpha in Adenomyosis.

Increased endometrial expression of CC-chemokine receptor-1 in women with adenomyosis.

[Distribution of Nerve Fibers in Endometrium and Its Clinical Significance in Adenomyosis].

Innervation of Endometrium and Myometrium in Women with Painful Adenomyosis and Uterine Fibroids.

Expression of Progesterone Receptor Subtypes in Ectopic Endometrium of Adenomyosis

Immunoreactivity of CD 68 , granulocyte-macrophage colony-stimulating factors receptor and vonWillebrand factor and its association with dysmenorrhea severity and the amount of menses in adenomyosis

The expression and methylation of PR-B in adenomyosis

Immunoreactivity of oxytocin receptor and transient receptor potential vanilloid type 1 and its correlation with dysmenorrhea in adenomyosis.

Increased Immunoreactivity to SLIT/ROBO1 and Its Correlation with Severity of Dysmenorrhea in Adenomyosis

Temporal and Spatial Expression of Estrogen Activity-Related Molecules in Eutopic Endometrium of Adenomyosis

Elevated Immunoreactivity Against Class I Histone Deacetylases in Adenomyosis.

Elevated Immunoreactivity to Tissue Factor and Its Association with Dysmenorrhea Severity and the Amount of Menses in Adenomyosis.

Aberrant Immunoreactivity of Deoxyribonucleic Acid Methyltransferases in Adenomyosis.

Cytokine Profiling in the Eutopic Endometrium of Adenomyosis During the Implantation Window after Ovarian Stimulation

Expression of Endometrial Receptivity Markers throughout the Menstrual Cycle in Women with and without Uterine Adenomyosis

Immunoreactivity of Progesterone Receptor Isoform B and Nuclear Factor Kappa-B As Biomarkers for Recurrence of Ovarian Endometriomas

Expression and clinical significance of Akt and NF-κB in adenomyosis

Study of Cell Apoptosis and Bcl-2 Expressions in the Ectopic Nidus of Adenomyosis

Mifepristone Inhibited the Expression of B7-H2, B7-H3, B7-H4 and PD-L2 in Adenomyosis

Decreased expression of killer cell inhibitory receptors on natural killer cells in eutopic endometrium in women with adenomyosis